Wegovy craze was all the rage on Q3 earnings calls
By Bhanvi Satija and Savyata Mishra (Reuters) – Weight loss was the talk of this earnings season, making names such as Wegovy, Ozempic and Mounjaro the water-cooler discussion that companies across the…
